Cargando…

Converting F(ENO) by different flows to standard flow F(ENO)

In clinical practice, assessment of expiratory nitric oxide (F(ENO)) may reveal eosinophilic airway inflammation in asthmatic and other pulmonary diseases. Currently, measuring of F(ENO) is standardized to exhaled flow level of 50 ml s(−1), since the expiratory flow rate affects the F(ENO) results....

Descripción completa

Detalles Bibliográficos
Autores principales: Lassmann‐Klee, Paul G., Lehtimäki, Lauri, Lindholm, Tuula, Malmberg, Leo Pekka, Sovijärvi, Anssi R.A., Piirilä, Päivi Liisa
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2019
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7003879/
https://www.ncbi.nlm.nih.gov/pubmed/31058423
http://dx.doi.org/10.1111/cpf.12574
Descripción
Sumario:In clinical practice, assessment of expiratory nitric oxide (F(ENO)) may reveal eosinophilic airway inflammation in asthmatic and other pulmonary diseases. Currently, measuring of F(ENO) is standardized to exhaled flow level of 50 ml s(−1), since the expiratory flow rate affects the F(ENO) results. To enable the comparison of F(ENO) measured with different expiratory flows, we firstly aimed to establish a conversion model to estimate F(ENO) at the standard flow level, and secondly, validate it in five external populations. F(ENO) measurements were obtained from 30 volunteers (mixed adult population) at the following multiple expiratory flow rates: 50, 30, 100 and 300 ml s(−1), after different mouthwash settings, and a conversion model was developed. We tested the conversion model in five populations: healthy adults, healthy children, and patients with COPD, asthma and alveolitis. F(ENO) conversions in the mixed adult population, in healthy adults and in children, showed the lowest deviation between estimated [Formula: see text] from 100 ml s(−1) and measured F(ENO) at 50 mL s(−1): −0·28 ppb, −0·44 ppb and 0·27 ppb, respectively. In patients with COPD, asthma and alveolitis, the deviation was −1·16 ppb, −1·68 ppb and 1·47 ppb, respectively. We proposed a valid model to convert F(ENO) in healthy or mixed populations, as well as in subjects with obstructive pulmonary diseases and found it suitable for converting F(ENO) measured with different expiratory flows to the standard flow in large epidemiological data, but not on individual level. In conclusion, a model to convert F(ENO) from different flows to the standard flow was established and validated.